INDUCTION OF P53 EXPRESSION BY NEUTRALIZATION OF NEUROPILIN-2 FOR THE TREATMENT OF CANCERS
摘要
<p>The present invention relates to the use of anti-human neuropilin-2 antibodies, or of ligands of human neuropilin-2 derived from these antibodies, for obtaining a medicament for increasing p53 expression and for inducing tumour cell apoptosis in the context of an anticancer treatment.</p>
